BSPM [Biostar Pharmaceuticals] NT 10-K: (Original Filing)

[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 ☒ ☐ ☐ (Check One): ☐ ☐ ☐ For Period Ended: December 31, 2017 ☐ ☐ ☐ ☐ ☐ For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained he]

By | 2018-04-03T02:00:49+00:00 April 2nd, 2018|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] NT 10-K: FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER:

[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 ☒ ☐ ☐ (Check One): ☐ ☐ ☐ For Period Ended: December 31, 2017 ☐ ☐ ☐ ☐ ☐ For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained he]

By | 2018-04-03T02:00:53+00:00 April 2nd, 2018|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMA] 10-K: (Original Filing)

[] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD84,849.59 respectively as of December 31, 2017. Due to the fact the Company temporarily did]

By | 2018-04-03T02:01:14+00:00 April 2nd, 2018|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMA] 10-K:

[] [Loans Extension Confirmation Letter Reference is made to the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest totaled USD1,354,567 and USD84,849.59 respectively as of December 31, 2017. Due to the fact the Company temporarily did]

By | 2018-04-03T02:01:18+00:00 April 2nd, 2018|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar